INCREASED PLATELET 3H-IMIPRAMINE BINDING AND MONOAMINE OXIDASE-B ACTIVITY IN ALZHEIMERS-DISEASE

被引:13
|
作者
BONUCCELLI, U [1 ]
PICCINI, P [1 ]
MARAZZITI, D [1 ]
CASSANO, GB [1 ]
MURATORIO, A [1 ]
机构
[1] UNIV PISA,INST PSYCHIAT,I-56100 PISA,ITALY
关键词
3 H-imipramine binding; Alzheimer's disease; monoamine oxidase B; Platelet;
D O I
10.1007/BF02260901
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several biochemical abnormalities in peripheral tissues have been reported in Alzheimer's disease (AD). With this in mind we studied platelet monoamine oxidase B (MAO B) activity and 3H-imipramine (IMI) binding in both AD patients and healthy subjects and found a significantly higher level of platelet MAO B activity and 3 H-IMI Bmax values in the AD patients. In view of the part that MAO B plays in metabolizing serotonin (5 HT) and of the relationship which exists between 3 H-IMI binding and 5 HT uptake, our results would suggest that with AD there occurs a complex dysfunction in the 5 HT system, at least at a peripheral level. © 1990 Springer-Verlag.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [41] Substrate specificity of human platelet monoamine oxidase B activity in Parkinson's and Alzheimer's disease
    Fitzgerald, DH
    Tipton, KF
    Anderson, MC
    Lawlor, B
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) : S63 - S63
  • [42] EFFECT OF PLASMA FROM PREMENSTRUAL-SYNDROME AND CONTROL PATIENTS ON HUMAN PLATELET AND RAT-BRAIN SYNAPTOSOME MONOAMINE OXIDASE-B ACTIVITY
    ASHBY, CR
    CARR, LA
    COOK, C
    STEPTOE, MM
    FRANKS, DD
    [J]. NEUROPSYCHOBIOLOGY, 1992, 25 (03) : 121 - 125
  • [43] 5-(AMINOMETHYL)-3-ARYLDIHYDROFURAN-2(3H)-ONES, A NEW CLASS OF MONOAMINE OXIDASE-B INACTIVATORS
    DING, ZZ
    SILVERMAN, RB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (05) : 885 - 889
  • [44] REDUCTIONS IN [H-3] NICOTINIC ACETYLCHOLINE BINDING IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE - AN AUTORADIOGRAPHIC STUDY
    WHITEHOUSE, PJ
    MARTINO, AM
    WAGSTER, MV
    PRICE, DL
    MAYEUX, R
    ATACK, JR
    KELLAR, KJ
    [J]. NEUROLOGY, 1988, 38 (05) : 720 - 723
  • [45] BIOCHEMICAL EFFECTS OF ANTIDEPRESSANT TREATMENT - STUDIES OF MONOAMINE METABOLITES IN CEREBROSPINAL-FLUID AND PLATELET [H-3] IMIPRAMINE BINDING
    ASBERG, M
    WAGNER, A
    [J]. CIBA FOUNDATION SYMPOSIA, 1986, 123 : 57 - 83
  • [46] Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients
    Zellner, Maria
    Baureder, Michael
    Rappold, Eduard
    Bugert, Peter
    Kotzailias, Nicole
    Babeluk, Rita
    Baumgartner, Roland
    Attems, Johannes
    Gerner, Christopher
    Jellinger, Kurt
    Roth, Erich
    Oehler, Rudolf
    Umlauf, Ellen
    [J]. JOURNAL OF PROTEOMICS, 2012, 75 (07) : 2080 - 2092
  • [47] QUANTITATIVE LOCALIZATION OF HUMAN BRAIN MONOAMINE OXIDASE-B BY LARGE SECTION AUTORADIOGRAPHY USING L-[H-3]DEPRENYL
    JOSSAN, SS
    GILLBERG, PG
    DARGY, R
    AQUILONIUS, SM
    LANGSTROM, B
    HALLDIN, C
    ORELAND, L
    [J]. BRAIN RESEARCH, 1991, 547 (01) : 69 - 76
  • [48] REDUCTIONS IN [H-3] ACETYLCHOLINE NICOTINIC BINDING-SITES IN CORTEX IN ALZHEIMERS-DISEASE - AN AUTORADIOGRAPHIC STUDY
    WHITEHOUSE, PJ
    MARTINO, AM
    MARCUS, K
    PRICE, DL
    KELLAR, KJ
    [J]. NEUROLOGY, 1986, 36 (04) : 270 - 270
  • [49] Alcohol-dependent patients with neuroendocrine evidence for reduced dopamine D2 receptor function have decreased platelet monoamine oxidase-B activity
    Berggren, U
    Fahlke, C
    Balldin, J
    [J]. ALCOHOL AND ALCOHOLISM, 2000, 35 (02): : 210 - 211
  • [50] HIGH-AFFINITY HIPPOCAMPAL [H-3] GLIBENCLAMIDE BINDING-SITES ARE PRESERVED IN ALZHEIMERS-DISEASE
    IKEDA, M
    DEWAR, D
    MCCULLOCH, J
    [J]. JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 5 (03) : 177 - 184